Filing Details
- Accession Number:
- 0001185185-15-003400
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2015-12-31 13:48:37
- Reporting Period:
- 2015-12-15
- Filing Date:
- 2015-12-31
- Accepted Time:
- 2015-12-31 13:48:37
- Original Submission Date:
- 2015-12-16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1530766 | Biosig Technologies Inc. | BSGM | Electromedical & Electrotherapeutic Apparatus (3845) | 264333375 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1261041 | Steve Chaussy | C/O Biosig Technologies, Inc. 8441 Wayzata Blvd., Suite 240 Minneapolis MN 55426 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value Per Share | Acquisiton | 2015-12-15 | 3,000 | $1.15 | 334,362 | No | 4 | P | Direct | |
Common Stock, $0.001 Par Value Per Share | Acquisiton | 2015-12-16 | 2,000 | $1.20 | 336,362 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Pursuant to Instruction 9(b) to Form 4, this amendment amends and restates the lines of transactions information in Table I of the original filing to correct the amount of securities beneficially owned following the reported transactions.